MacroGenics (MGNX) PT Lowered to $42 at Stifel; Reiterates Buy
Tweet Send to a Friend
Stifel lowered its price target on MacroGenics (NASDAQ: MGNX) to $42.00 (from $51.00) while maintaining a Buy rating.Analyst Stephen Willey ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
